Senseonics Reports $0.71 EPS Loss, Beats Revenue Estimates
Senseonics posted a Q1 loss of $0.71 per share, missing the $0.65 consensus and widening from a $0.40 loss a year earlier. Quarterly revenue exceeded analysts’ estimates, suggesting improving commercial traction in sensor sales.
1. Q1 EPS Loss Widened Year-over-Year
Senseonics recorded a net loss of $0.71 per share for the first quarter, compared with a $0.40 per share loss in the year-ago period and missing the $0.65 per share loss analysts had forecast. The wider loss reflects increased operating expenses as the company expanded its commercialization efforts.
2. Revenue Performance Exceeds Estimates
Although specific revenue figures were not disclosed, Senseonics reported that Q1 sales topped consensus expectations, highlighting stronger-than-anticipated demand for its implantable glucose monitoring sensors. This revenue beat points to growing market acceptance of the company’s Eversense platform.